Pyridostigmine Bromide Tablet, Extended Release
Product Images NDC 47781-335

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 47781-335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label (Bottle Label)

This is a medication with NDC number 47781-335-30 that contains 180 Pyridostigmine Bromide extended-release tablets. It is important to keep the tablets dry with the silica gel enclosed as they are moisture sensitive. The dosage and other important information are provided in the accompanying package insert. Store at controlled room temperature and dispense in tight containers as defined in the USP/NF. Made in the USA, distributed by Alvogen, Inc in Pine Brook, NJ.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.